Scott E. Eggener to Enzyme Inhibitors
This is a "connection" page, showing publications Scott E. Eggener has written about Enzyme Inhibitors.
Connection Strength
0.315
-
Editorial comment on: Pharmacological approaches to reducing the risk of prostate cancer. Eur Urol. 2009 May; 55(5):1073-4.
Score: 0.261
-
Enhancement of intermittent androgen ablation by "off-cycle" maintenance with finasteride in LNCaP prostate cancer xenograft model. Prostate. 2006 Apr 01; 66(5):495-502.
Score: 0.054